Balyasny Asset Management’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
2019
Q2
$1.21M Sell
2019
Q1
$2.67M Hold
2018
Q4
$915K Hold
2018
Q3
$4.4M Hold
2018
Q2
$4.66M Hold
2018
Q1
$5.98M Hold
2017
Q4
$8.12M Buy
2017
Q3
$3.88M Hold
2017
Q2
$5.4M Buy
2015
Q3
Sell
2015
Q2
$4.16M Sell
2015
Q1
$3.65M Sell
2014
Q4
$5.99M Buy
2014
Q3
$927K Buy